![webinars-art-final webinars-art-final](https://www.ispor.org/images/default-source/event-images/event-content-type-images/webinars-art-final.png?sfvrsn=7973dd9_3)
September 13, 2022
Open to all ISPOR Members and Non-members
Title: How Can Society Sustainably Benefit From Biosimilars? Global Learnings and Policy Recommendations for Australia
7:00PM EDT | 11:00PM UTC | 1:00AM CEST
Click here for time zone conversion
Register Here
Description
This webinar leverages recent global research conducted across 17 countries to provide an overview of the challenges and solutions to ensure the biosimilar benefits are sustainably delivered to the whole society. There will be a specific focus on the issues in Australia and comparing those against examples found globally. Implications for patients, society as well as a discussion of the learnings in terms of policy provisions and best practices that can help solving these issues will also be held.
Learning Objectives
- Improved understanding of country-specific policy issues that hinder access and use of biosimilars.
- Consideration of policy changes that help delivering the value of biosimilars to the society.
Moderators:
Rowan Saada, Consulting Associate, Charles River Associates, London, England, UK
Michele Pistollato, PhD, Charles River Associates, London, England, UK
Speakers:
George Tambassis, BPharm, CEO, Biosimilars Academy Arrotex Biologics, Melbourne, Australia
Andrew Ostor, MD, Consultant Rheumatologist, St. Francis Cabrini Medical Center, Melbourne, Australia
Cheryl Koehn, BA, CEO, Arthritis Consumer Experts, Vancouver, Canada
Please note: On the day of the scheduled webinar, the first 1000 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later date, the
full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 days after the scheduled Webinar.